P. Rouanet et al., PROCTECTOMY AND COLOANAL ANASTOMOSIS AFTE R HIGH-DOSE RADIATION FOR CARCINOMA OF THE LOWER 3RD OF THE RECTUM - FUNCTIONAL AND ONCOLOGICAL RESULTS, Annales de chirurgie, 48(6), 1994, pp. 512-519
This prospective study was designed to evaluate morbidity and function
al and onological outcomes in patients with carcinoma of the distal th
ird of the rectum treated by high-dose radiation therapy followed by c
onservative surgery. Twenty-two patients with adenocarcinoma of the di
stal third of the rectum treated after June 1990 were included in the
study. Mean distances separating the tumor from the upper edge of the
levator ani muscle and from the anal verge were 17 mm and 47 mm, respe
ctively. None of the tumors were fixed; preoperative stage, establishe
d by endoscopic ultrasound, was T2 in 12 patients and T3 in 10. Patien
ts received induction radiation therapy in two series delivered three
weeks apart (40 Gy on the pelvis, then 20 Gy on the tumor only) follow
ed by surgical resection (proctectomy with colo-anal anastomosis in 17
cases and amputation in five). After radiation, two tumors were negat
ive for malignant cells, 12 were Astler-Coller B1, two were B2, and si
x were C2. Mean safety margin after colo-anal anastomosis was 16.8 mm;
all the resection margins were negative. Mortality and morbidity were
not increased by the high-dose radiation protocol. Conservation of th
e sphincter was possible in 80% of patients. All the patients were con
tinent. Functional outcome was rated good in 77% of cases, fair in 9%
and poor in 4%. During the mean follow-up of 24 months, there were thr
ee disease-related deaths, including one due to a strictly regional re
currence; metastatic dissemination to the lungs occurred in two patien
ts and the remaining 17 patients (80%) were disease-free. These data s
uggest that high-dose radiation therapy followed by conservative surge
ry ensures satisfactory functional outcomes in patients with carcinoma
s of the distal rectum. Evaluation of oncological outcomes will requir
e a longer follow-up.